GenFleet Therapeutics completes HK$466.90 million H-share placing and updates share capital structure

Bulletin Express07-17

GenFleet Therapeutics (Shanghai) Inc. announced the successful completion of its previously disclosed H-share placing on 17 July 2026. All conditions under the placing agreement have been met, and the new shares have been issued under the company’s existing general mandate.

A total of 13.60 million new H shares were placed with at least six independent investors at HK$34.69 per share. The transaction generated gross proceeds of HK$471.80 million and net proceeds of approximately HK$466.90 million after commission and expenses. The newly issued shares account for 3.87 % of the company’s enlarged H-share class and 3.54 % of total issued shares.

Following the placement, GenFleet Therapeutics’ total share count increased from 370.37 million to 383.97 million. The H-share tally rose to 351.63 million, while unlisted shares remained at 32.34 million. The new investors collectively hold 3.54 % of the company; no individual placee became a substantial shareholder under Hong Kong listing rules.

To reflect the expanded capital base, the board has amended the Articles of Association pursuant to prior shareholder authorization. Registered capital now stands at RMB38.40 million, corresponding to 383.97 million shares. Required registrations and filings with regulators in mainland China and Hong Kong are in progress.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1183578809?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-17 20:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1183578809","market":"hk","top_or_hot":-1,"title":"GenFleet Therapeutics completes HK$466.90 million H-share placing and updates share capital structure","media":"Bulletin Express","content":"<p>GenFleet Therapeutics (Shanghai) Inc. announced the successful completion of its previously disclosed H-share placing on 17 July 2026. All conditions under the placing agreement have been met, and the new shares have been issued under the company’s existing general mandate.</p>\n<p>A total of 13.60 million new H shares were placed with at least six independent investors at HK$34.69 per share. The transaction generated gross proceeds of HK$471.80 million and net proceeds of approximately HK$466.90 million after commission and expenses. The newly issued shares account for 3.87 % of the company’s enlarged H-share class and 3.54 % of total issued shares.</p>\n<p>Following the placement, GenFleet Therapeutics’ total share count increased from 370.37 million to 383.97 million. The H-share tally rose to 351.63 million, while unlisted shares remained at 32.34 million. The new investors collectively hold 3.54 % of the company; no individual placee became a substantial shareholder under Hong Kong listing rules.</p>\n<p>To reflect the expanded capital base, the board has amended the Articles of Association pursuant to prior shareholder authorization. Registered capital now stands at RMB38.40 million, corresponding to 383.97 million shares. Required registrations and filings with regulators in mainland China and Hong Kong are in progress.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>GenFleet Therapeutics completes HK$466.90 million H-share placing and updates share capital structure</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGenFleet Therapeutics completes HK$466.90 million H-share placing and updates share capital structure\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-07-17 20:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>GenFleet Therapeutics (Shanghai) Inc. announced the successful completion of its previously disclosed H-share placing on 17 July 2026. All conditions under the placing agreement have been met, and the new shares have been issued under the company’s existing general mandate.</p>\n<p>A total of 13.60 million new H shares were placed with at least six independent investors at HK$34.69 per share. The transaction generated gross proceeds of HK$471.80 million and net proceeds of approximately HK$466.90 million after commission and expenses. The newly issued shares account for 3.87 % of the company’s enlarged H-share class and 3.54 % of total issued shares.</p>\n<p>Following the placement, GenFleet Therapeutics’ total share count increased from 370.37 million to 383.97 million. The H-share tally rose to 351.63 million, while unlisted shares remained at 32.34 million. The new investors collectively hold 3.54 % of the company; no individual placee became a substantial shareholder under Hong Kong listing rules.</p>\n<p>To reflect the expanded capital base, the board has amended the Articles of Association pursuant to prior shareholder authorization. Registered capital now stands at RMB38.40 million, corresponding to 383.97 million shares. Required registrations and filings with regulators in mainland China and Hong Kong are in progress.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02595","symbol_name":"劲方医药-B","start_time":0,"source_url":"","article_id":"1183578809","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1183578809","pubTimestamp":1784289741,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"GenFleet Therapeutics (Shanghai) Inc. announced the successful completion of its previously disclosed H-share placing on 17 July 2026. All conditions under the placing agreement have been met, and...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02595":"劲方医药-B"},"translate_title":"GenFleet Therapeutics完成4.669亿港元H股配售并更新股本架构","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02595":1},"content_text":"GenFleet Therapeutics (Shanghai) Inc. announced the successful completion of its previously disclosed H-share placing on 17 July 2026. All conditions under the placing agreement have been met, and the new shares have been issued under the company’s existing general mandate.\nA total of 13.60 million new H shares were placed with at least six independent investors at HK$34.69 per share. The transaction generated gross proceeds of HK$471.80 million and net proceeds of approximately HK$466.90 million after commission and expenses. The newly issued shares account for 3.87 % of the company’s enlarged H-share class and 3.54 % of total issued shares.\nFollowing the placement, GenFleet Therapeutics’ total share count increased from 370.37 million to 383.97 million. The H-share tally rose to 351.63 million, while unlisted shares remained at 32.34 million. The new investors collectively hold 3.54 % of the company; no individual placee became a substantial shareholder under Hong Kong listing rules.\nTo reflect the expanded capital base, the board has amended the Articles of Association pursuant to prior shareholder authorization. Registered capital now stands at RMB38.40 million, corresponding to 383.97 million shares. Required registrations and filings with regulators in mainland China and Hong Kong are in progress.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1183578809","isCrawlerRequest":true}